The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Investigating macrophage function as a mechanism of resistance to daratumumab in relapsed refractory multiple myeloma patients.
 
Swetha Kambhampati
No Relationships to Disclose
 
Kwun Wah Wen
No Relationships to Disclose
 
Victoria Sung
Employment - Arch Oncology
Stock and Other Ownership Interests - Arch Oncology
 
Sandy Wai Kuan Wong
Consulting or Advisory Role - Amgen; Amgen
Research Funding - Fortis (Inst); Fortis (Inst); Genentech (Inst); Genentech (Inst); Janssen (Inst); Janssen (Inst)
 
Thomas G. Martin
Consulting or Advisory Role - Juno Therapeutics; Roche; TeneoBio
Research Funding - Amgen (Inst); Genentech/Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Roche
 
Jeffrey Lee Wolf
Stock and Other Ownership Interests - Celgene
Honoraria - Onyx
Consulting or Advisory Role - Celgene; Janssen; Novartis; Takeda; Telomere Diagnostics
Speakers' Bureau - Millenium Pharamceuticals
Travel, Accommodations, Expenses - Celgene; Janssen; Millenium Pharamceuticals; Novartis; Onyx
 
Nina Shah
Stock and Other Ownership Interests - Indapta Therapeutics
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech/Abbvie; Indapta Therapeutics; Karyopharm Therapeutics; Nektar; Nkarta; Oncopeptides; Precision Biosciences; Sanofi; Seagen; Surface Oncology; TeneoBio
Research Funding - Bluebird Bio; Celgene; Janssen; Sutter Medical Group
 
Arun Wiita
Leadership - Indapta Therapeutics; Protocol Intelligence
Stock and Other Ownership Interests - Indapta Therapeutics; Protocol Intelligence
Consulting or Advisory Role - Indapta Therapeutics
Research Funding - Quadriga Biosciences; Sutter Medical Group; TeneoBio
Patents, Royalties, Other Intellectual Property - Inventor on patent filed by UCSF